EHS
EHS

Crash and burn: Why three biotechs failed in 2018



There is an appointed time for everything — including in biotech. There is a time to start a company, a time to wind it down, a time to go public, and a time to delist the stock.

For every hopeful biotech toiling for decades before finally realizing a profit, there are countless others that run out of money or bet on a product that never delivers.

Read the rest…

Source link

EHS
Back to top button